TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms

[News]

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

More... (https://www.news-medical.net/news/20181029/TherapeuticsMD-announces-FDA-approval-of-BIJUVA-capsules-to-manage-vasomotor-symptoms-of-menopause.aspx)